These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2477560)

  • 21. Brain metastasis as a sole recurrence of prostate cancer after total prostatectomy.
    Hayashi T; Igarashi K; Tanizawa A; Terada Y; Sekine H
    Urol Int; 1998; 60(2):121-3. PubMed ID: 9563153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
    Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ
    Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The results of radical prostatectomy at a community hospital during the prostate specific antigen era.
    Smitt MC; Heltzel M
    Cancer; 1996 Mar; 77(5):928-33. PubMed ID: 8608486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy.
    Blute ML; Nativ O; Zincke H; Farrow GM; Therneau T; Lieber MM
    J Urol; 1989 Nov; 142(5):1262-5. PubMed ID: 2810503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer.
    Stein A; deKernion JB; Smith RB; Dorey F; Patel H
    J Urol; 1992 Mar; 147(3 Pt 2):942-6. PubMed ID: 1371565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The surgical learning curve for prostate cancer control after radical prostatectomy.
    Vickers AJ; Bianco FJ; Serio AM; Eastham JA; Schrag D; Klein EA; Reuther AM; Kattan MW; Pontes JE; Scardino PT
    J Natl Cancer Inst; 2007 Aug; 99(15):1171-7. PubMed ID: 17652279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radical prostatectomy and radical radiation therapy for clinical stages T1 to 2 adenocarcinoma of the prostate: new insights into outcome from repeat biopsy and prostate specific antigen followup.
    Zietman AL; Shipley WU; Coen JJ
    J Urol; 1994 Nov; 152(5 Pt 2):1806-12. PubMed ID: 7523726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies.
    Oefelein MG; Smith N; Carter M; Dalton D; Schaeffer A
    J Urol; 1995 Dec; 154(6):2128-31. PubMed ID: 7500474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?
    Sokoll LJ; Zhang Z; Chan DW; Reese AC; Bivalacqua TJ; Partin AW; Walsh PC
    J Urol; 2016 Feb; 195(2):330-6. PubMed ID: 26307160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma.
    Hammond ME; Sause WT; Martz KL; Pilepich MV; Asbell SO; Rubin P; Myers RP; Farrow GM
    Cancer; 1989 Feb; 63(3):461-6. PubMed ID: 2463874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of patient age on biochemical recurrence rates following radical prostatectomy.
    Magheli A; Rais-Bahrami S; Humphreys EB; Peck HJ; Trock BJ; Gonzalgo ML
    J Urol; 2007 Nov; 178(5):1933-7; discussion 1937-8. PubMed ID: 17868723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urethral metastasis from prostatic carcinoma as diagnosed by immunoperoxidase technique using prostate-specific antigen and prostate-specific acid phosphatase.
    Koh E; Sekii K; Namiki M; Fujioka H; Onoue K; Sakurai M; Sonoda T
    Eur Urol; 1987; 13(1-2):142-4. PubMed ID: 2438138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate specific antigen and local recurrence after radical prostatectomy.
    Lightner DJ; Lange PH; Reddy PK; Moore L
    J Urol; 1990 Oct; 144(4):921-6. PubMed ID: 1697917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.
    Kositsawat J; Flanigan RC; Meydani M; Choi YK; Freeman VL
    J Urol; 2007 Dec; 178(6):2391-6; discussion 2396. PubMed ID: 17936811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radical prostatectomy for clinical stage T3a disease.
    Freedland SJ; Partin AW; Humphreys EB; Mangold LA; Walsh PC
    Cancer; 2007 Apr; 109(7):1273-8. PubMed ID: 17315165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasensitive prostate specific antigen and its role after radical prostatectomy: a systematic review.
    Tilki D; Kim SI; Hu B; Dall'Era MA; Evans CP
    J Urol; 2015 May; 193(5):1525-31. PubMed ID: 25444980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of predicting long-term prostate specific antigen outcome based on early prostate specific antigen recurrence results after radical prostatectomy.
    Soergel TM; Koch MO; Foster RS; Bihrle R; Wahle G; Gardner T; Jung SH
    J Urol; 2001 Dec; 166(6):2198-201. PubMed ID: 11696735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and molecular followup after radical retropubic prostatectomy.
    Oefelein MG; Ignatoff JM; Clemens JQ; Watkin W; Kaul KL
    J Urol; 1999 Aug; 162(2):307-10; discussion 310-1. PubMed ID: 10411026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables.
    Ferrari MK; McNeal JE; Malhotra SM; Brooks JD
    Urology; 2004 Oct; 64(4):749-53. PubMed ID: 15491714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An analysis of urinary prostate specific antigen before and after radical prostatectomy: evidence for secretion of prostate specific antigen by the periurethral glands.
    Iwakiri J; Granbois K; Wehner N; Graves HC; Stamey T
    J Urol; 1993 Apr; 149(4):783-6. PubMed ID: 7681118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.